打印本文 打印本文 关闭窗口 关闭窗口
Nogo-66 蛋白的免疫原性研究-在体实验
作者:岳红云 贺…  文章来源:第三军医大学大坪医院野战外科研究所眼科,贺翔鸽 重庆 400042)  点击数1491  更新时间:2007/6/20 9:44:40  文章录入:aya610  责任编辑:毛进
Purpose: To investigate the immunogenicity of Nogo-66 protein which artificially conposited templeting from cDNA of human Nogo gene and to offer the initial proof for immunotherpy in injured central nerve system. Method: To immunise the experimental animals by Nogo-66 protein and detected IgG in blood surem for verifying the change in humoral-mediated immunity,detected the percentage of T cell in S and G2/M tage to know the change about potential improving of cell mediated immunity at the preimmunse and postimmunised alter time point by 5d、7d、10d、14d、 20d、28d、36d、48d and 4d、8d、16d、20d. Consequence: The immused animals show more IgG and T cells of Stage than control groups. The peak numerical value of IgG occurrence during the 16~24d and the T cell in S tage is 8~ 16d.The results exhibited significant distinction to control groups. Conclusion: The immusing of Nogo-66 protein can improve both the humoral-mediated immunity and cell-mediated immunity can be proved by ex vivo, so, we try to study if it can be used in immunotherapy to injured CNS based on above mentioned effect.
打印本文 打印本文 关闭窗口 关闭窗口